Effects of AGTR1 A1166C Gene Polymorphism in Patients with Heart Failure Treated with Candesartan
Simon de Denus(Montreal Heart Institute), Michel White(Montreal Heart Institute), Anique Ducharme(Montreal Heart Institute), Rhian M. Touyz(McGill University Health Centre), Marie‐Pierre Dubé(Montreal Heart Institute), Normand Racine(Montreal Heart Institute), Marie-Hélène Leblanc, Denis Gossard(Cégep Saint-Jean-sur-Richelieu), Jacques Turgeon(Unknown), Marcin Zakrzewski‐Jakubiak(Université de Montréal), François Bélanger(Hôpital Maisonneuve-Rosemont), Serge Lepage, Joël Lavoie(Montreal Heart Institute), Lucette Whittom(Montreal Heart Institute)
Cited by 41
Related Papers
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Clinical Practice Guidelines for the Management of Hypertension in the Community
|Journal of Clinical Hypertension|2013|1k
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
|Nature Genetics|2003|976
Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina
|Journal of the American College of Cardiology|2018|772